FBLG

FibroBiologics (FBLG)

FibroBiologics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FBLG

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/01	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/12/31	06 : 30	GlobeNewswire Inc.	FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing	NASDAQ:FBLG	FibroBiologics Inc
2024/12/31	06 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBLG	FibroBiologics Inc
2024/12/31	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBLG	FibroBiologics Inc
2024/12/31	04 : 12	GlobeNewswire Inc.	D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing	NASDAQ:FBLG	FibroBiologics Inc
2024/12/30	22 : 29	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:FBLG	FibroBiologics Inc
2024/12/23	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/12/23	21 : 55	GlobeNewswire Inc.	FibroBiologics Announces $25 Million Financing	NASDAQ:FBLG	FibroBiologics Inc
2024/12/21	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/11/19	23 : 15	GlobeNewswire Inc.	FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly	NASDAQ:FBLG	FibroBiologics Inc
2024/11/14	23 : 15	GlobeNewswire Inc.	FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics	NASDAQ:FBLG	FibroBiologics Inc
2024/11/13	06 : 20	GlobeNewswire Inc.	FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:FBLG	FibroBiologics Inc
2024/11/13	06 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FBLG	FibroBiologics Inc
2024/10/30	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/10/29	22 : 15	GlobeNewswire Inc.	FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology	NASDAQ:FBLG	FibroBiologics Inc
2024/10/28	22 : 31	GlobeNewswire Inc.	FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024	NASDAQ:FBLG	FibroBiologics Inc
2024/10/18	21 : 30	GlobeNewswire Inc.	FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases	NASDAQ:FBLG	FibroBiologics Inc
2024/10/16	22 : 15	GlobeNewswire Inc.	FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office	NASDAQ:FBLG	FibroBiologics Inc
2024/10/11	22 : 31	GlobeNewswire Inc.	FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit	NASDAQ:FBLG	FibroBiologics Inc
2024/09/30	22 : 31	GlobeNewswire Inc.	FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa	NASDAQ:FBLG	FibroBiologics Inc
2024/09/25	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/09/19	22 : 31	GlobeNewswire Inc.	FibroBiologics Engages Southern Star Research as CRO in Australia	NASDAQ:FBLG	FibroBiologics Inc
2024/09/12	22 : 31	GlobeNewswire Inc.	FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology	NASDAQ:FBLG	FibroBiologics Inc
2024/09/06	22 : 31	GlobeNewswire Inc.	FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:FBLG	FibroBiologics Inc
2024/08/29	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/08/28	08 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBLG	FibroBiologics Inc
2024/08/28	08 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBLG	FibroBiologics Inc
2024/08/28	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBLG	FibroBiologics Inc
2024/08/20	22 : 31	GlobeNewswire Inc.	FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology	NASDAQ:FBLG	FibroBiologics Inc
2024/08/15	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FBLG	FibroBiologics Inc